|24.43||+0.42 / +1.75%|
As of 3:59pm ET
|25.70||+1.27 / +5.20%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +14.61% increase from the last price of 24.43.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.